Skip to main content
. 2017 Jan 5;72(4):1152–1162. doi: 10.1093/jac/dkw545

Figure 1.

Figure 1

Schematic representation of the source of both nevirapine-hypersensitive and -tolerant patients for the GWAS discovery and replication cohorts.